Service Providers for HER2
HER2 (human epidermal growth factor receptor 2) is a protein that can drive cancer growth when overexpressed, common in certain breast and gastric cancers. Testing HER2 status through immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) determines if the cancer is HER2-positive, guiding treatment decisions. HER2-positive cancers respond well to targeted therapies like trastuzumab, improving patient outcomes.